Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
Recent news and posts
Dutch ZonMw accepts applications for grants for further research under the 2021-2024 HTA Methodology Program
To give researchers more tools to assess healthcare innovations' efficiency and demonstrate the effectiveness of novel technologies, the Dutch Organization for Health Research and Development (ZonMw), in collaboration with the National Health Care Institute (ZIN), initiated the new HTA Methodology Program for 2021-2024.
On September 21, 2023, ZonMw announced the submission of grant applications for the development or validation of methodology that is useful for the evaluation of technology in healthcare on the aspect of work deployment. Work deployment can also be a part or side outcome of a methodology that considers multiple outcomes. This methodology must be widely applicable, i.e., it can be applied to various technologies.
A total of €1.4 million is available, with a maximum amount of €250,000 per project for 24 months. The submission of grant applications will continue until January 9, 2024.
The full details in Dutch can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.